SIGA's Short-Term Move Belies Long-Term Potential

By VFC: Even on a day when the DOW drops 300 points at the open, there's sure to be a good news story somewhere.

By VFC: Siga's (SIGA) dropping share price over the months since being awarded a government contract for its smallpox antiviral ST-246 is evidence enough that many in the market predicted a negative decision from the judge that would rule on the legal battle with PharmAthene (

VFC submits: Keep an eye on Siga Technologies (SIGA) this week. The company announced after the closing bell on Friday that it had signed a much-anticipated agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services to deliver an initial two million doses of the antiviral smallpox vaccine ST-246 to the nation's stockpile of biodefenses.

By VFC: Interest has been all over Human Genome Sciences (HGSI) lately since a rumor originated from across the pond in mid October that GlaxoSmithKline (GSK

By VFC: Shares of Siga Technologies (SIGA) closed on a high last week after comments made by Siga board member Fran Townsend to CNN circulated the media wires and reassured investors that the large government contract awarded to Siga by the Biomedical Advanced Research and Development Authority of the Un

Frank Voisin submits: SIGA Technologies, Inc. (SIGA) is a biotechnology company that focuses on the development and commercialization of products related to serious infectious diseases. It is currently the only company in the world to have a successful cure (rather than a preventative vaccine) for smallpox (ST-246). The U.S.

Todd Johnson submits:Human Genome Sciences (HGSI) is finally coming to market with the full FDA approved medication. The company's early years hype, and later years near-death stock experience, can all be viewed in perspective.

VFC submits: Barely a week following news that it had received the first FDA approval for a new lupus drug in over half a century, Human Genome Sciences (HGSI) made a move to boost the long term viability of its pipeline.